Iowa Governor Chet Culver to Cut the Ribbon on New Genencor Facility

Thursday, September 17, 2009 General News J E 4
- Grand Opening event for Cedar Rapids Applied Innovation Center & Plant Expansion -


Grand Opening event for Genencor Grain Processing Applied Innovation Center.

Genencor is a division of Danisco A/S.


Tuesday, September 15, 2009

11:00 am - barbecue reception and tours begin

1:00 pm - official ribbon cutting ceremony, with remarks from Governor Culver, Danisco CEO, Tom Knutzen, and other honored guests


Genencor: 1000 41st Avenue Dr, SW, Cedar Rapids, IA 52404-5048


Iowa Governor Chet Culver will join Genencor's senior management and other honored guests to cut the ribbon on Genencor's new 20,000-square-foot Grain Processing Applied Innovation Center and expanded 140,000-square-foot enzyme manufacturing plant. The projects represent a combined investment of $52 million. Numerous customers from ethanol and carbohydrates processing companies will attend, along with employees. In addition to the ribbon cutting ceremony and festivities, the event will include tours of Genencor's world-class laboratory and enzyme manufacturing center.

Interview and photo opportunities:

About Genencor

Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance for a spectrum of industries, from biofuels and laundry detergents to animal nutrition and food. As part of a large global organization, Genencor has a manufacturing and distribution network that spans more than 40 countries.

For more information contact:

Jennifer Hutchins, +1 585 256 6973

-- Danisco and Genencor senior executives and grain processing technology experts will be on hand for interviews. -- The event will offer many photo opportunities, including honored guests on tour in the facility. Photographs will be permitted in designated areas within the lab and plant facilities.

SOURCE Genencor


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Regions Hospital Selected to Participate in Nation...
Par Pharmaceutical Receives Final Approval To Mark...